1Monika L,Metzger,Jeffrey S,et al.Current therapy for wilms'tumor.The Oncologist,2005 ;10(10):815 -826.
2Gordan M,Vujanic,Bengt Sandstedt,et al.Revised international society of paediatric oncology(SIOP) working classification of renal tumors of childhood.Med Pediatr Oncol,2002 ;38:79-82.
3John A Kalapurakala,Jeffrey S Domec,Elizabeth J Perlmanb,et al.Management of Wilms' turnout:currenr practice and future goals.Lancet Oncol,2004 ;5 (1):37-46.
4Pizzo PA,Poplack DG.Principles and Practice of Pediatric Ontology.4th Edition.Philadelphia,USA:Lippincott Williams & Wilkins,2001:866-887.
5Jereb B,Burgers M,Tournade M,et al.Radiotherapy in the SlOP (International Society of Pediatric Oncology).Med Pediatr Oncol,1994;22(4) ;221 -227.
6Tournade MF,Com-Nougue C,de Kraker J,et al.Optimal duration of preoperative therapy in unilateral and nonmetastafic Wilms'tumor in children older than 6 months:results of the Ninth International Society of Pediatric Ontology Wilms' Tumor Trial and Study.J Clin Oncol,2001; 19:488-500.
7de Kraker J,Graf N,van Tinteren H,et al.Reduction of postoperative chemotherapy in children with stage I intermediate-risk and anaplastic Wilms' tumor (SLOP 93-01 trial):a randomised controlled trial.Lancet,2004 ;364:1229-1235.
9D' Angio GJ,Breslow N,Beckwith JB,et al.Treatment of Wilms'tumor:Results of the Third National Wilms' Tumor Study.Cancer,1989 ;64:349-360.
10Green DM,Breslow NE,Beckwith JB,et al.Comparison between singledose and divided-dose administration of dactinomyein and doxorubicin for patients with Wilms' tumor:a report from the National Wihns' Tumor Study Group.J Clin Oncol,1998;16:237-245.
6[3]Kraker J,Graf N,Tinteren H,et al.Redution of postoperative chemotherapy in children with stage I intermediate-risk and anaplastic Wikms tumor (SLOP 93-01 trial):A randomized controlled tria[J].Lancet,2004,364:1 229-1 235.
